Trial intelligence / Profile preview

Thalidomide in Refractory Epilepsy

NCT01061866Phase 2Completed

Start
Jun 2006
Primary completion
Jun 2007
Modality
Small Molecules
01

Overview

A Phase 2 trial of thalidomide in epilepsy. Started Jun 2006; status: completed.

02

Drugs

thalidomide
03

Conditions

epilepsy

Beyond the preview

Go deeper on NCT01061866.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01061866.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call